Le Lézard
Classified in: Health
Subject: AWD

Dr. Nikesh Seth Receives PHOENIX Magazine's 2018 Top Doc Award


SCOTTSDALE, Ariz., June 20, 2018 /PRNewswire-PRWeb/ -- Arizona pain management doctor Nikesh Seth of Integrated Pain Consultants was named one of PHOENIX Magazine's Top Doctors for the fourth straight year. Top Doctors is a peer-selected list of the Phoenix Metropolitan area's best physicians. It is compiled using an annual survey of local health care professionals.

Dr. Seth is a standout in his field. He is Double Board Certified in Anesthesiology and Interventional spine and pain management and offers over 30 state of the art treatment options including radiofrequency ablation, spinal cord stimulator implants, and several new types of epidural steroid injections.

Dr. Seth has participated in studies of pain management treatments and currently serves as a member of the faculty for the University of Arizona College of Medicine and Scottsdale Healthcare Residency Program.

The 2018 Top Doc award is no surprise to Dr. Seth's patients who say his compassion, customized treatment plans, and ability to provide personal attention set him apart from others in his field. In fact, over 95% of his patients achieve pain relief within the first two visits and avoid potentially risky surgery.

Integrated Pain Consultants has three offices in Scottsdale, Mesa, and Phoenix, Arizona. New patients can schedule an evaluation by calling (480) 626-2552 or book an appointment online at: http://www.azipc.com.

 

SOURCE Integrated Pain Consultants


These press releases may also interest you

at 17:00
StateHouse Provides an Update on Application for Management Cease Trade Order
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols 2023 Annual Report on Form 20-F filed with the SEC
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
FDA Roundup: April 19, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor eyes SEIU-CUPE award for Ontario health care members
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

More news about Health...


News published on and distributed by: